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Distribution of Histone3 Lysine 4
Trimethylation at T3-Responsive Loci
in the Heart During Reversible
Changes in Gene Expression
KUMAR PANDYA,*1 TAKAHIDE KOHRO,†1 IMARI MIMURA,† MIKA KOBAYASHI,†
YOUICHIRO WADA,† TATSUHIKO KODAMA,† AND OLIVER SMITHIES*
*Department of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill,
Chapel Hill, NC, USA
†Department of Molecular Biology and Medicine, The Research Center for Advanced Science and Technology,
The University of Tokyo, Tokyo, Japan
Expression in the adult heart of a number of cardiac genes, including the two genes comprising the cardiac
myosin heavy chain locus (Myh), is controlled by thyroid hormone (T3) levels, but there is minimal information
concerning the epigenetic status of the genes when their expressions change. We fed mice normal chow or a
propyl thio uracil (PTU, an inhibitor of T3 production) diet for 6 weeks, or the PTU diet for 6 weeks followed
by normal chow for a further 2 weeks. Heart ventricles from these groups were then used for ChIP-seq analyses
with an antibody to H3K4me3, a well-documented epigenetic marker of gene activation. The resulting data show
that, at the Myh7 locus, H3K4me3 modifications are induced primarily at 5′ transcribed region in parallel with
increased expression of beta myosin heavy chain (MHC). At the Myh6 locus, decreases in H3K4me3 modifica-
tions occurred at the promoter and 5′ transcribed region. Extensive H3K4me3 modifications also occurred at the
intergenic region between the two Myh genes, which extended into the 3′ transcribed region of Myh7. The PTU-
induced changes in H3K4me3 levels are, for the most part, reversible but are not invariably complete. We found
full restoration of Myh6 gene expression upon PTU withdrawal; however, the H3K4me3 pattern was only
partially restored at Myh6, suggesting that full reexpression of Myh6 does not require that the H3K4me3 modifi-
cations return fully to the untreated conditions. Together, our data show that the H3K4me3 modification is an
epigenetic marker closely associated with changes in Myh gene expression.
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INTRODUCTION (14,17). Multiple studies have revealed predictive cor-
relations between histone modifications and gene
expression (6,18). Trimethylation of lysine residue atThe amino-terminal tails of histones are the target
of multiple posttranslational modifications: acetyla- position 4 of histone 3 (H3K4me3) is one such modi-
fication that is highly correlated with active genetion, methylation, phosphorylation, and ubiquitination
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expression (24). Genome-wide studies have found inducing or silencing the expression of target genes
(2). THR binds to its recognition site independentlythis modification to be present frequently within the
promoters of genes that are actively transcribed, and of T3, although the presence or absence of T3 con-
trols whether THR is a transcriptional activator orit is now considered to be a well-conserved marker
of gene activation (16,29). Several components of the transcriptional repressor.
The two genes of the Myh locus, Myh6 and Myh7,transcriptional machinery contain domains (such as
PHD, chromo, bromo, MCT, and Tudor) that can rec- are some of the most T3-responsive genes in the
heart. They code for the developmental stage-specificognize H3K4me3 (12). The H3K4me3 modification
may serve as a general means of recruiting transcrip- isoforms of the myosin heavy chain component of the
sarcomere—the fundamental unit of contraction oftional machinery. Determining how the distribution
of H3K4me3 modification changes in response to the muscle cell. Myh7 (beta-MHC) is expressed at
high levels during the fetal stage in the mouse ventri-defined stimuli is critical to understanding how genes
are regulated. cle, during which Myh6 (alpha-MHC) is expressed at
very low levels. Immediately after birth, in response toThyroid hormone (T3) is a fat-soluble hormone
produced by the thyroid gland, which is released into a surge in the circulating levels of T3, the expression
of Myh7 is silenced and that of Myh6 increases sothe circulation and plays critical roles in differentia-
tion, growth, and metabolism (30). The effects of T3 that alpha-MHC becomes the predominant isoform of
myosin heavy chain. Under conditions of hypothyroid-on heart function are well documented, and various
studies have identified multiple genes whose expres- ism, heart failure, and cardiac hypertrophy, there is a
reversal in the expression pattern of these two genes:sion levels are responsive to T3 levels, including the
two cardiac myosin heavy chain (Myh) genes, sarco- Myh7 expression is induced and Myh6 is silenced.
The degree to which T3-mediated changes in Myhplasmic reticulum Ca2+ ATPase, and several mem-
brane-bound sodium and potassium channels (3,11, gene expression are associated with changes in
H3K4me3 levels is of considerable interest, as is the21). T3 binds to the thyroid hormone receptor
(THR)—a member of nonsteroidal nuclear hormone degree to which H3K4me3 modification is reversible
during reversible changes in gene expression. Previousreceptor family—and exerts its effects by either
Figure 1. H3K4me3 enrichment profile of Myh loci. H3K4me3 signal intensities are shown on the y-axis and schematic of the Myh locus
shown on the x-axis. Animals were fed either regular chow (untreated), PTU diet for 6 weeks (PTU), or PTU diet for 6 weeks followed by
regular chow for a further 2 weeks (reversal), and hearts were isolated for analyses. ChIP-seq analyses were conducted using anti-H3K4me3
antibody from chromatin isolated from untreated (U, top panel), PTU-treated (P, middle panel), or reversal (R, bottom panel) animals.
H3K4me3 signals are illustrated from the Integrated Genome Browser interface. Exons are represented as closed boxes; bent arrows show
the transcriptional start site (TSS) and direction of transcription. Intergenic region between the two Myh genes is identified with a horizontal
bar. Individual peaks are identified by letters in italics. Scale bar for the locus is shown at the bottom left.
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Figure 2. H3K4me3 enrichment profile of Myh intergenic region. H3K4me3 signal intensities are shown on the y-axis and schematic of the
locus shown on the x-axis. Animals were fed either regular chow (untreated), PTU diet for 6 weeks (PTU), or PTU diet for 6 weeks followed
by regular chow for a further 2 weeks (reversal), and hearts were isolated for analyses. ChIP-seq analyses were conducted using anti-
H3K4me3 antibody from chromatin isolated from Untreated (U, top panel), PTU-treated (P, middle panel), or reversal (R, bottom panel)
animals. Exons are represented as closed boxes; bent arrows show the transcriptional start site (TSS) and direction of transcription. Intergenic
region between the two Myh genes is identified with a horizontal bar. Individual peaks are identified by letters in italics. Scale bar for the
locus is shown at the bottom left.
work conducted by us using a chromatin immuno- ChIP-seq procedure. This combines ChIP with deep
sequencing, which results in a sensitive and unbiasedprecipitation (ChIP)-qPCR assay demonstrated that
this modification occurred at the promoter of Myh6 way of investigating the H3K4me3 status within indi-
vidual genes across the whole genome. Here, webut not Myh7 (20). However, this previous investiga-
tion did not interrogate regions outside the promoters. show that the H3K4me3 modification occurs at mul-
tiple regions within the Myh locus, including theConsequently, in this report, we have comprehen-
sively investigated the changes in H3K4me3 levels 5′ transcribed portion of Myh7. We also show
H3K4me3 modification at an intergenic region thatacross the entire Myh loci using the more powerful
Figure 3. Reversible changes in mRNA expression levels of Myh genes in response to PTU treatment. Comparisons of mRNA expressions
for Myh6 (A) and Myh7 (B) from hearts of untreated (U), PTU-treated (P), and reversal (R) groups. The mean for untreated group (for
Myh6) or PTU-treated group (for Myh7) was set at 100, and the values for the other groups are relative to this value (relative expression).
Animals were fed either regular chow (U), PTU diet for 6 weeks (P), or PTU diet for 6 weeks followed by regular chow for a further 2
weeks (R), and hearts were isolated for analyses. Quantitative gene expressions were determined by Taqman real-time PCR. Individual
values ± SD are: Myh6 (U): 100 ± 4; Myh6 (P): 8 ± 4; Myh6 (R): 115 ± 8; Myh7 (U): 0.2 ± 0.01; Myh7(P): 100 ± 5.7; Myh7(R): 0.9 ± 0.1.
IP: 103.62.30.226 On: Thu, 26 Apr 2018 07:20:33
Article(s) and/or figure(s) cannot be used for resale. Please use proper citation format when citing this article including the DOI,
publisher reference, volume number and page location.
Delivered by Ingenta
186 PANDYA ET AL.
TABLE 1
Rx257896) for 6 weeks, and then either sacrificedT3-RESPONSIVE HEART GENES
(PTU group) or fed normal chow for another 2 weeks
Actg2 Actin, gamma 2, smooth muscle, enteric (reversal). Control mice were fed normal chow. The
Aldoc Aldose C, fructose-bisphosphate mice were maintained in a facility accredited by the
Ankrd1 Ankyrin repeat domain 1 protein
Association for the Assessment and Accreditation ofAtp1b1 Sodium/Potassium-transporting ATPase subunit beta-1
Laboratory Animal Care International according toAtp2a2 ATPase, Ca2+ transporting, cardiac muscle, slow twitch2
Atp5a1 Mitochondrial H+-ATPase synthase alpha subunit Institutional Animal Care and Use Committee-
Brp44l Brain protein 44-like approved guidelines.
Bpnt1 3′(2′),5′-bisphosphate nucleotidase
Cacna1c Ca2+ channel
Organ Preparation for ChromatinCtrb1 Chymotrypsin B
Cycs Cytochrome C Immunoprecipitation (ChIP)
Cx3c Chemokin Cx3c
Hearts were excised immediately after euthanasiaDab2 DOC-2 p82 isoform
Dcn Decorin and cut into two pieces to remove residual blood.
Fabp3 Adipocyte lipid-binding protein Then they were washed in PBS and snap frozen in
Fbp1 Fructose 1,6-biphosphate liquid nitrogen. Hearts were treated with 1% formal-
Fxyd5 FXYD domain-containing ion transport regulator-1
dehdye for 20 min, followed by treatment with gly-Hr Hairless
cine to quench fixation. Nuclear extracts wereItga7 Alpha7A integrin
Kcna5 Potassium channel a5 prepared by crushing with Cryo-Press CP-100
Kcnb1 Potassium channel b1 (Microtech Nichion, Co. Ltd, Japan), as described
Kcnd2 Potassium channel d2 previously (27). Briefly, approximately 300 mg of
Kcne1 Potassium channel e1
frozen heart tissue was physically crushed with Cryo-Kcnj11 Sulfonyl urea receptor
Press for 1 min four times, changing direction of liq-Kcnk2 Potassium channel k2
Kcnq1 Potassium channel q1 uid nitrogen-cooled sample container. Frozen powder
Mdh1 Malate dehydrogenase-like enzyme of heart was immediately suspended in 2 ml of SDS
Mgp Matrix G1a protein lysis buffer (10 mM Tris-HCl, pH 8.0, 150 mM
Myh6 Cardiac myosin heavy chain, alpha
NaCl, 1% SDS, 1 mM EDTA). Cell suspensionMyh7 Cardiac nyosin heavy chain, beta
including DNA–protein complex was applied to frag-Myh13 Myosin, heavy chian polypeptide, 13, skeletal muscle
Nppa Natriuretic peptide precursor A mentation using Sonifier (Branson); 10 min for high-
Nppb Brain natriuretic factor speed sequencer. Samples were diluted by 2 ml of
Nrp1 Neuropilin ChIP dilution buffer (20 mM Tris-HCl, pH 8.0, 150
Pln Phospholamban
mM NaCl, 1 mM EDTA, 1% Triton X-100) andRgs4 Regulator of G-protein signaling 4
applied to chromatin immunoprecipitation. DetailedS100a4 S100 calcium binding protein A4
Slc8a1 Ca2+ regulatory channel experimental procedure for chromatin immunoprecip-
Slc2a4 Glucose transporter 4, insulin responsive itation followed with high-speed sequencer was mod-
Tmprss13 Protease, serine, 11 (IgF binding) ified as described elsewhere (28). H3K4me3-bound
Tnp2 Transition protein 2
genomic DNA was isolated from whole cell lysateWfdc8 WAP four-disulfide core domain 8
using a mouse monoclonal antibody [16H10, a gift
Putative T3-resposnive genes whose expression was previously of Dr. Hiroshi Kimura (13)], in combination with
shown to change >2× in response to changes in T3 levels (1,15). magnetic beads (Dynal/Invitrogen). Prepared DNA
was quantified using Qubit (Invitrogen) and more
than 10 ng of DNA was processed as described below.
coincides with a previously demonstrated antisense
promoter. Finally, we show that the H3K4me3 modi- ChIP-seq Sample Preparation and Analysis
fication occurs at many regions within the genome
All protocols for Illumina/Solexa sequence prepa-and that it is at least partially reversible in response






Ventricles of the hearts from the different condi-
tions were surgically isolated, frozen in liquid nitro-Animals used in this study were 4-month-old 129/
Svev. Animals were fed an iodine-deficient diet con- gen, and RNA isolated. Total RNA was submitted for
microarray analyses as previously described (27).taining 0.15% PTU (Harlan Teklad, TD. 97061,
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Figure 4. Schematic of H3K4me3 enrichment profile of T3-responsive genes that respond to PTU treatment. Relative H3K4me3 signal
intensities are shown on the y-axis and schematics of individual gene loci shown on the x-axis. ChIP-seq analyses were conducted using
anti-H3K4me3 antibody from chromatin isolated from untreated (U, top panel), PTU-treated (P, middle panel), or reversal (R, bottom panel)
animals. Exons are represented as closed boxes; bent arrows show the transcriptional start site (TSS) and direction of transcription. Quantita-
tion of these data is presented in Tables 2 and 3. Vertical arrows in (D, F, G) (Hr, Kcnj11, and Pln) identify H3K4me3 peaks that are
present in untreated (U) but not in reversal (R) conditions, depicting incomplete reversal. Genes whose loci showed >2× or <2× changes in
H3K4me3 levels in response to PTU were considered PTU responsive. Scale bars for each locus are shown at the bottom left of each panel.
RESULTS throughput sequencing (ChIP-seq) analyses on heart
samples, which enables analysis of H3K4me3 distri-
ChIP-seq Analyses for H3K4me3 Occupancy
bution across the whole genome. We used cardiac
ventricles from 4-month-old 129/Svev mice and con-The distribution of the H3K4me3 modification was
determined by chromatin immunoprecipitation/high ducted ChIP-seq assays with an antibody specific for
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Figure 4. Continued.
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Figure 5. Schematic of H3K4me3 enrichment profile of T3-responsive genes that do not respond to PTU. Relative H3K4me3 signal intensi-
ties are shown on the y-axis and schematic of individual gene loci shown on the x-axis. ChIP-seq analyses were conducted using anti-
H3K4me3 antibody from chromatin isolated from untreated (U, top panel), PTU-treated (P, middle panel), or reversal (R, bottom panel)
animals. Exons are represented as closed boxes; bent arrows show the transcriptional start site (TSS) and direction of transcription. Quantita-
tion of these data is presented in Tables 2 and 3. Scale bars for each locus are shown at the bottom left of each panel.
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TABLE 2
the H3K4me3 modification. The sites and levels ofCHANGES IN H3K4me3 LEVELS AMONG
PUTATIVE T3-RESPONSIVE GENES H3K4me3 modification were determined by massive
parallel sequencing on an Illumina deep sequencing
Gene Ctl PTU Rev PTU/ Rev/
platform. Distribution patterns of H3K4me3 wereSymbol Levels Levels Levels Ctrl Ratio PTU Ratio
quantified and graphically visualized with an inte-
Myh6 68026 0 21573 0.0 — grated genome browser, which depicts H3K4me3
Rgs4 2000 0 8942 0.0 — levels on the y-axis and the locus map for each gene
Mgp 20267 602 42947 0.0 71.4
on the x-axis.Pln 20090 1134 \N7021 0.1 6.2
Nppb 18315 2351 3857 0.1 1.6
Hr 18641 2638 7858 0.1 3.0 Distribution of H3K4me3 Modification
Kcnj11 34836 6006 0 0.2 0 at the Myh Locus
Kcnd2 19304 3331 1535 0.2 0.5
Slc2a4 32417 6319 8694 0.2 1.4
Untreated Mice. We first analyzed the distribu-Kcnb1 14129 2766 3523 0.2 1.3
tion of H3K4me3 in untreated animals, which expressSlc8a1 49337 11331 40608 0.2 3.6
Itga7 51115 14827 33826 0.3 2.3 Myh6 at high levels and Myh7 at very low levels.
Atp1b1 57529 16998 16922 0.3 1.6 The top panel (U, untreated) of Figure 1 illustrates
Fabp3 95984 31582 44893 0.3 1.4 the distribution pattern of H3K4me3 signals at the
Atp2a2 84817 29090 47822 0.3 1.6
Myh loci. A schematic of the locus is shown at theAnkrd1 17212 5936 3077 0.3 0.5
bottom of the figure. Under untreated conditions,Cx3cl1 29320 10314 21145 0.4 2.1
Dab2 42588 17915 69258 0.4 3.9 Myh6 shows two regions of H3K4me3 enrichment.
Nrp1 171188 74166 179050 0.4 2.4 One region lies within the Myh6 promoter [peak h,
Mdh1 47128 22051 49320 0.5 2.2 located at −1.0 kb relative to the transcription start
Atp5a1 105564 49696 84171 0.5 1.7
site (TSS)]. The other region is located within the 5′Kcnk2 17021 8040 1352 0.5 0.2
transcribed portion (peaks a through g in Fig. 1,Kcnq1 105988 50258 80012 0.5 1.6
Brp44l 101490 50152 88572 0.5 1.8 between TSS and +8.5 kb relative to TSS) of Myh6
Bpnt1 74190 38480 57761 0.5 1.5 gene. The presence of these H3K4me3 modifications
Kcna5 66864 35810 44242 0.5 1.2 within Myh6 is consistent with the high level of
Cacna1c 8782 4837 6618 0.6 1.4
expression of Myh6. Myh7, on the other hand, showsCycs 47220 28252 43321 0.6 1.5
essentially undetectable H3K4me3 signals within theFxyd5 26130 17449 33009 0.7 1.9
Myh7 1160 12730 0 11.0 0 promoter and most of the transcribed portion of the
Actg2 ND ND ND — — gene in the untreated mice. This lack of H3K4me3
Aldoc ND ND ND — — modification at Myh7 is consistent with the very low
Ctrb1 ND ND ND — —
expression of Myh7 under untreated conditions.Dcn ND ND 10456 — —
Interestingly, a region of H3K4me3 enrichment isFbp1 ND ND ND — —
found at the intergenic region between the two Myh
Kcne1 ND ND ND — — genes, which is seen as multiple peaks (peaks i
through n in Fig. 1) beginning at approximately 2.5kb
Myh13 ND ND ND — —
upstream of Myh6 TSS and extending approximately
4 kb into the 3′ transcribed portion of Myh7 [illus-Nppa ND ND ND — —
trated in greater detail in Fig. 2, top panel (U)].
S100a4 ND ND ND — —
PTU-Treated Mice. To change the expression
Tmprss13 ND ND ND — —
levels of the two Myh genes, we induced a hypothy-
roid condition by feeding mice a diet containingTnp2 ND ND ND — —
0.15% PTU for 6 weeks. PTU is a specific inhibitor
Wfdc8 ND ND ND — — of thyroid hormone synthesis, and it has been well
established that this level of PTU in the diet is suffi-
Quantification of H3K4me3 levels within putative T3-reponsive
cient to induce changes in the heart that are typicalgenes under untreated (Ctrl), PTU-treated (PTU), and reversal
of hypothyroid conditions (15,22,26). PTU treatment(Rev) conditions. ND, not detected. Changes in H3K4me3 levels
were quantified based on values for ChIP-seq. dramatically silences Myh6 expression and substan-
tially increases Myh7 gene expression (22,26). In our
mice, mRNA analyses using real-time PCR from the
PTU-treated and untreated hearts show, as expected,
a substantial silencing of Myh6 (approximately 10-
fold decrease) and a dramatic increase in Myh7 gene
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TABLE 3
QUANTITATION OF H3K4me3 LEVELS AT VARIOUS REGIONS IN INDIVIDUAL GENES
5′ First Other All 3′
Gene Condition Promoter UTR Intron Introns Exons UTR
Myh6 Control 48029 19997 0 0 0 0
PTU 0 0 0 0 0 0
Reversal 14496 7077 0 0 0 0
Rgs4 Control 0 0 2000 0 0 0
PTU 0 0 0 0 0 0
Reversal 0 280 7806 0 857 0
Mgp Control 0 568 13329 4456 1915 0
PTU 0 0 521 0 81 0
Reversal 0 451 29793 10286 2417 0
Pln Control 0 8643 6843 0 1956 848
PTU 0 567 567 0 0 0
Reversal 0 3511 3511 0 0 0
Nppb Control 0 646 2817 7903 6950 0
PTU 0 248 0 0 2103 0
Reversal 0 0 558 1344 1955 0
Hr Control 5697 6496 822 211 5434 0
PTU 0 1325 185 0 1128 0
Reversal 0 3938 746 0 3174 0
Kcnj11 Control 0 2688 0 0 28240 3809
PTU 0 355 0 0 3665 986
Reversal 0 0 0 0 0 0
Kcnd2 Control 19304 0 0 0 0 0
PTU 3331 0 0 0 0 0
Revesal 1535 0 0 0 0 0
Slc2a4 Control 0 2239 20953 2367 6858 0
PTU 0 1142 3625 0 1552 0
Reversal 0 975 6325 0 1395 0
Kcnb1 Control 12711 709 0 0 709 0
PTU 2231 268 0 0 268 0
Reversal 2523 0 0 0 0 0
Slc8a1 Control 0 24675 24293 0 369 0
PTU 0 5665 5665 0 0 0
Reversal 0 20304 20304 0 0 0
Itga7 Control 0 2936 36801 0 11378 0
PTU 0 364 11509 0 2954 0
Reversal 0 2067 22184 0 9575 0
Atp1b1 Control 0 7670 37385 0 12474 0
PTU 0 2245 10793 0 3959 0
Reversal 0 1765 20615 0 4543 0
Fabp3 Control 4334 0 37385 0 2997 0
PTU 0 0 1073 0 1083 0
Reversal 0 0 20615 0 1320 0
Atp2a2 Control 0 11767 30530 20653 20866 0
PTU 0 5172 14109 0 9808 0
Reversal 0 1002 22140 19106 5575 0
Ankrd1 Control 0 0 5317 6689 5206 0
PTU 0 0 1614 1416 2906 0
Reversal 0 0 1527 0 1550 0
Cx3cl1 Control 0 1848 21708 0 5764 0
PTU 0 505 8164 0 1644 0
Reversal 0 1046 16856 0 3243 0
(continued)
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TABLE 3
CONTINUED
5′ First Other All 3′
Gene Condition Promoter UTR Intron Introns Exons UTR
Dab2 Control 0 21308 18574 0 2706 0
PTU 0 8964 7828 0 1123 0
Reversal 0 34650 31026 0 3581 0
Nrp1 Control 41277 13383 92480 2449 21600 0
PTU 20895 7504 34309 0 11458 0
Reversal 31449 13472 111118 637 22375 0
Mdh1 Control 0 4922 37028 0 5179 0
PTU 0 3587 14715 0 3750 0
Reversal 0 3735 35533 0 7051 0
Atp5a1 Control 0 6115 79019 7882 12548 0
PTU 0 3650 39448 0 6598 0
Revesal 0 4569 68859 2682 8061 0
Kcnk2 Control 0 0 7909 0 596 8517
PTU 0 0 3356 0 658 4026
Reversal 0 0 676 0 0 676
Kcnq1 Control 0 1330 16363 76913 11382 0
PTU 0 470 8176 35882 5731 0
Reversal 0 276 2575 71598 5563 0
Brp44I Control 3623 1955 88258 0 7654 0
PTU 547 944 44962 0 3699 0
Reversal 2989 2044 76059 0 7522 0
Bpnt1 Control 53583 10332 7823 0 2452 0
PTU 28490 5006 4043 0 941 0
Reversal 34568 10117 8414 0 1662 0
Kcna5 Control 0 4902 0 0 60396 1566
PTU 0 2298 0 0 33471 41
Reversal 0 3248 0 0 39730 1264
Cacna1c Control 3540 5242 0 0 0 0
PTU 1976 2861 0 0 0 0
Reversal 2456 4162 0 0 0 0
Cycs Control 0 23373 21723 0 2124 0
PTU 0 14144 13296 0 813 0
Reversal 0 21429 20621 0 1272 0
Fxyd5 Control 0 12495 9107 476 4051 0
PTU 0 7831 5846 1067 2706 0
Reversal 0 14289 11825 3119 3776 0
Myh7 Control 0 0 0 0 0 1160
PTU 0 0 12730 0 0 0
Reversal 0 0 0 0 0 0
Actg2 Control 0 0 0 0 0 0
PTU 0 0 0 0 0 0
Reversal 0 0 0 0 0 0
Aldoc Control 0 0 0 0 0 0
PTU 0 0 0 0 0 0
Reversal 0 0 0 0 0 0
Ctrb1 Control 0 0 0 0 0 0
PTU 0 0 0 0 0 0
Reversal 0 0 0 0 0 0
Dcn Control 0 0 0 0 0 0
PTU 0 0 0 0 0 0
Reversal 7907 0 1279 108 1161 0
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TABLE 3
CONTINUED
5′ First Other All 3′
Gene Condition Promoter UTR Intron Introns Exons UTR
Fbp1 Control 0 0 0 0 0 0
PTU 0 0 0 0 0 0
Reversal 0 0 0 0 0 0
Kcne1 Control 0 0 0 0 0 0
PTU 0 0 0 0 0 0
Reversal 0 0 0 0 0 0
Myh13 Control 0 0 0 0 0 0
PTU 0 0 0 0 0 0
Reversal 0 0 0 0 0 0
Nppa Control 0 0 0 0 0 0
PTU 0 0 0 0 0 0
Reversal 0 0 0 0 0 0
S100a4 Control 0 0 0 0 0 0
PTU 0 0 0 0 0 0
Reversal 0 0 0 0 0 0
Tmprss13 Control 0 0 0 0 0 0
PTU 0 0 0 0 0 0
Reversal 0 0 0 0 0 0
Tnp2 Control 0 0 0 0 0 0
PTU 0 0 0 0 0 0
Reversal 0 0 0 0 0 0
Wfdc8 Control 0 0 0 0 0 0
PTU 0 0 0 0 0 0
Reversal 0 0 0 0 0 0
Quantification of H3K4me3 levels at different regions within putative T3-reponsive genes under untreated (Ctrl),
PTU-treated (PTU), and reversal (Rev) conditions. ND, not detected. Changes in H3K4me3 levels were quantified
based on values for ChIP-seq.
expression (approximately 50-fold increase) in are absent at the Myh7 promoter when it is expressed
in the adult heart under hypothyroid condition (20).response to PTU (Fig. 3). The middle section (P) of
Figure 1 illustrates the H3K4me3 distribution under The intergenic region, noted above, completely loses
the H3K4me3 signals during PTU treatment (notePTU-treated conditions. At the Myh6 locus this treat-
ment leads to a dramatic decrease of the H3K4me3 absence of peaks i though n in panel P, Figs. 1 and 2).
signals to undetectable levels (reduction to <20% of
its maximal value, a level below which random noise Reversal Mice. We next determined the degree to
which the PTU-induced changes in H3K4me3 distri-predominates) at the two regions of the gene that
showed high levels of H3K4me3 modification in the bution at the Myh locus reverse when the gene
expression levels are reversed, which our previousuntreated mice (peaks a through n in Fig. 1). This
loss of H3K4me3 modification is consistent with the work shows is complete by 2 weeks after withdrawal
of PTU. Accordingly, mice were treated with PTUgreatly reduced level of gene expression. At the
Myh7 locus, PTU treatment causes the development for 6 weeks, PTU treatment was then withdrawn, and
2 weeks later we sacrificed the mice. Real-time PCRof two new peaks of H3K4me3 enrichment. One peak
is at +0.5 kb (peak p in Fig. 1) and the other peak is analyses for mRNA expression show that Myh6 gene
expression returns to its original high levels, whilelocated at +2.5kb (peak o in Fig. 1) relative to the
Myh7 TSS. This gain of H3K4me3 modification is expression of Myh7 is reduced dramatically to its
original low levels (Fig. 3). ChIP-seq analyses con-consistent with the greatly increased expression lev-
els of Myh7. There are, however, no H3K4me3 peaks ducted on the hearts of these animals show that the
PTU-induced changes in H3K4me3 enrichmentpresent within the Myh7 promoter, confirming our
previous observation that H3K4me3 modifications within the Myh7 gene have likewise returned to the
IP: 103.62.30.226 On: Thu, 26 Apr 2018 07:20:33
Article(s) and/or figure(s) cannot be used for resale. Please use proper citation format when citing this article including the DOI,
publisher reference, volume number and page location.
Delivered by Ingenta
194 PANDYA ET AL.
untreated levels. Thus, as illustrated in bottom panel in the promoter (peak h) reattained under reversal
conditions. The heights of the H3K4me3 modifica-(R) of Fig. 1, the two H3K4me3 peaks (peaks o and
p) present at Myh7 gene under PTU conditions tion within the 5′ transcribed portion were also
reduced under reversal condition compared with thedecrease dramatically during reversal to levels below
the threshold and so indistinguishable from those of untreated condition (compare peaks e, f, and g with
peaks e′, f′, and g′, respectively, in Fig,. 1). The inter-untreated animals. The Myh6 gene shows increases
in the H3K4me3 levels within the 5′ transcribed por- genic region also shows increases in the levels of
H3K4me3 modification. However, similar to the situ-tion during reversal, but neither the levels nor the pat-
terns are restored to their untreated levels. The peaks ation for Myh6, some peaks (peaks i, m, and n in
Figs. 1 and 2) are not reattained, and some peaksa, b, and c present in the 5′ transcribed region are not
reattained during reversal conditions. Nor is the peak show decreased heights (compare peaks j, k, and l
Figure 6. Validation of ChIP-seq data. Top: ChIP-qPCR analyses for H3K4me3 at the Myh6 transcribed region. % enrichment (relative to
100% input) of immunoprecipitated DNA is shown on y-axis and the various locations (TSS, transcription start site, +3 kb, +5 kb) of Myh6
are shown on the x-axis. ChIP-qPCRs were conducted using anti-H3K4me3 antibody form chromatin isolated from untreated (U, open bars),
PTU-treated (P, black bars), or reversal (R, gray bars) animals. Data represent mean of seven independent ChIP experiments from four
individual animals within each group. Error bars represent SEM. *p < 0.05 (relative to untreated group), #p < 0.005 (relative to PTU group).
These data are reproduced from a previously published work (20). Bottom: Chip-seq analyses of Myh6 gene. Part of Figure 1 is shown
below the graph for ease of comparison. Scale bar for the locus is shown at the bottom left.
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TABLE 4
to T3 (1,15) (Table 1). Inspection of the H3K4me3CHANGES IN mRNA LEVELS AMONG
PUTATIVE T3-RESPONSIVE GENES distribution patterns of these 40 genes in the
untreated mice show that 28 have detectable
Gene Symbol PTU/Ctrl Ratio Rev/PTU Ratio
H3K4me3 modifications indicative of expression [top
Tmprss13 0.2 2.6 panel (U) of Figs. 4 and 5] These H3K4me3 peaks
Hr 0.3 2.5 are distributed primarily at the 5′ transcribed portions
Myh6 0.3 3.1 of these genes, as has been observed for other
Rgs4 0.4 2.5
actively transcribed genes. PTU treatment changedKcnb1 0.5 2.9
the level of H3K4me3 modification significantlyKcnq1 2.1 0.4
Kcne1 3.6 0.4 (defined as >2× changes in H3K4me3 levels in either
Myh7 3.0 0.1 direction) in 18 of these genes [middle panel (P) of
Actg2 — — Fig. 4], while the remaining 10 genes did not show a
Atp2a2 — —
significant PTU-response [middle panel (P) of Fig.Atp5a1 — —
5]. Under conditions of reversal, H3K4me3 levelsBpnt1 — —
Cx3cl1 — — within these 18 genes had a tendency to return to the
Cycs — — original untreated conditions [bottom panel (R) of
Dab2 — — Fig. 4], although the levels did not always show full
Dcn — —
recovery. Six genes (Kcnj11, Hr, Pln, Nppb, Slc2a4,Fabp3 — —
and Ankrd1) do not show full recovery. Kcnj11 lociFxyd5 — —
Itga7 — — shows dramatically reduced H3K4me3 levels under
Kcna5 — — reversal conditions, compared to untreated conditions
Kcnd2 — — (Fig. 4F), while the H3K4me3 peaks present in the
Kcnj11 — —
promoter of Hr and Slc2a4 (arrows, Fig. 4E and H,Mdh1 — —
respectively), 5′ transcribed portion of Pln (arrows,Mgp — —
Nppa — — Fig. 4C), and within the gene of Nppb and Anrd1
Nppb — — (arrows, Fig. 4D and O, respectively) are not reat-
Nrp1 — — tained under reversal conditions. Interestingly, one
Pln — —
gene (Dcn) that had previously showed undetectedS100a4 — —
levels of H3K4me3 under untreated and PTU condi-Slc2a4 — —
Slc8a1 — — tions shows detectable levels of H3K4me3 levels
Aldoc ND ND under conditions of reversal (Fig. 5K). Quantified
Ankrd1 ND ND values of H3K4me3 levels at the entire loci of all
Atp1b1 ND ND
these genes are shown in Table 2, and the distribu-Brp44l ND ND
tions within various regions of individual genes areCacna1c ND ND
Ctrb1 ND ND shown in Table 3.
Fbp1 ND ND We compared the ChIP-seq data for Myh6
Kcnk2 ND ND described in this work with ChIP-qPCR analyses of
Myh13 ND ND
Myh6 carried out previously by us (20) in response toTnp2 ND ND
PTU treatment and PTU reversal. The previous ChIP-Wfdc8 ND ND
qPCR analyses showed that the +3 kb and +5 kb
Changes in mRNA levels of putative T3-reponsive genes under regions of Myh6 gene had significant reversible
untreated (Ctrl), PTU-treated (PTU), and reversal (Rev) conditions. decreases in H3K4me3 signals in response to PTU
Genes whose expression changed <2× are denoted by —. ND, not
treatment (Fig. 6, black bars), while the TSS regiondetected. Changes in mRNA levels were quantified based on
of Myh6 gene showed no changes in H3K4me3 lev-microarray analyses.
els in response to these treatments. These ChIP-qPCR
data are in complete agreement with the ChIP-seqwith peaks j′, k′, and l′, respectively, in Figs. 1 and
data for Myh6 at these locations presented in this2). Thus, reversal of gene expression of Myh genes to
report (Fig. 6, bottom panel).untreated levels results in a full reversal of H3K4me3
We also examined whether the T3-responsivemodification at the Myh7 gene, but that at the Myh6
genes that showed changes in H3K4me3 levels alsogene is only partial.
showed changes in gene expression. To do this, we
Distribution of H3K4me3 Modification in Other conducted microarray analyses from hearts of mice
T3-Responsive Genes from the three groups, and the results are shown in
Table 4. Eight out of 42 genes show significantForty genes, in addition to Myh6 and Myh7, have
been shown by previous investigators to be responsive changes in mRNA levels (determined as >2× change
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in either direction). Six of these genes (Myh6, Rgs4, intergenic region of the cardiac MHC locus, in con-
firmation of several previous reports demonstratingHr, Kcnb1, Kcnq1, and Myh7) also showed changes
in H3K4me3 levels, while two genes (Tmprss13 and the presence of an antisense intergenic promoter at
this location (4,5,7,9). This antisense promoter isKcne1) did not show any detectable H3K4me3 sig-
nals at their respective loci. thought to direct a transcript across the Myh7 gene
and may play a role in controlling the switch between
Myh6 and Myh7 gene expression. Multiple binding
sites for the THR are present within this intergenicDISCUSSION
region, and previous work suggests that this promoter
is under the control of T3, and has documented theThe ChIP-seq procedure combines chromatin
immunoprecipitation with high-throughput direct presence of a PTU-responsive change in the levels of
h3k9/14 ac and h3k4/k9 me3 at this intergenic pro-sequencing of short fragments of DNA (19,31). The
method is devoid of sequence bias and has great sen- moter (8). Consistent with this our data show that
PTU treatment leads to a dramatic reduction ofsitivity and consequently provides a way of mapping
a wide variety of histone modifications across the H3K4me3 modification in this region, which is
reversed when the PTU treatment is ceased, and thewhole genome (10,23). In this study we have applied
this procedure to investigate the distribution of intergenic changes correlates with changes occurring
within the Myh6 gene. Together, these observationsH3K4me3 marks at the Myh locus in response to
reversible changes in gene expression triggered by of T3-mediated epigenetic changes in H3K4me3 sig-
nals at this location make a strong case for the pres-chemical inhibition of T3 synthesis.
Our ChIP-seq analyses show a correlation between ence of a functional antisense promoter in this
intergenic region.H3K4me3 signals and the gene expression status of
Myh6 and Myh7 genes. When Myh6 gene expression Our analyses demonstrate that 18 other putative
T3-responsive genes show very modest changes inis high, as under untreated and reversal conditions,
we find detectable levels of H3K4me3 at the Myh6 H3K4me3 levels in response to PTU. All of these are
reductions in the levels of H3K4me3, consistent withlocus. Similarly, when Myh7 gene expression is high,
as under conditions of PTU treatment, we find detect- previous observations that the vast majority of T3-
responsive genes are positively regulated by T3.able levels of H3K4me3 modifications at the Myh7
locus. When Myh6 gene expression is silenced, as Since cardiac myocytes do not divide in the adult
mouse heart to any appreciable degree, any decreasesunder conditions of PTU treatment, H3K4me3 levels
also drops to low levels at the Myh6 locus. Similarly, in H3K4me3 levels must be a direct result of active
removal of the modification via demethylase ratherwhen Myh7 gene expression is silenced, under
untreated and reversal conditions, H3K4me3 modifi- than being the result of dilution due to cell division.
Even though Myh6 gene expression levels fullycations likewise drop to low levels.
Our previous work using ChIP-qPCR showed that returned to their original state, the H3K4me3 modifi-
cation within the Myh6 locus only partially returnedthe promoter of Myh7 did not show detectable
changes in H3K4me3 modifications in response to to the original state. Thus, some peaks that were pres-
ent under untreated conditions were absent underPTU-induced changes in gene expression (20). Con-
sistent with these previous ChIP-qPCR data, our cur- reversal conditions, while other peaks had a marked
decrease in amplitude, although the expression levelsrent ChIP-seq data do not show PTU-induced
changes in the levels of H3K4me3 levels in the pro- were comparable between the two conditions. The
achievement of full restoration of Myh6 gene expres-moter region of Myh7. Rather, the distribution of this
modification occurs at a region downstream of the sion, even though the H3K4me3 pattern is only par-
tially restored, shows that full reexpression of Myh6TSS. Thus, our new ChIP-seq data imply that if
H3K4me3 modifications play a role in the expression does not require that the H3K4me3 modifications
return fully to the untreated conditions. The degreeof the Myh7 gene, it is not by changing the modifica-
tion levels in the promoter region. The significance of reversal also varied at the non-Myh loci. Thus, one
gene (Kcnj11) showed no reversal while five genesof the differences in H3K4me3 modification at the
two Myh promoters remains to be determined. (Hr, Pln, Nppb, Slc2a4, and Ankrd1) showed partial
reversal of the H3K4me3 distribution when PTU wasInterestingly, our data show the presence of a
region of H3K4me3 modification in the intergenic withdrawn. Since each nucleosome contains two h3
molecules, a single nucleosome can have at leastregion between Myh6 and Myh7 under untreated
conditions, beginning approximately 2.5 kb upstream three discrete H3K4me3 modification states: zero
(both h3k4 unmodified), one (only one H3K4me3of Myh6 TSS and extending for 6.5 kb into the 3′
region of Myh7. This observation is a strong indi- modified), or two (both h3k4 modified). The partial
H3K4me3 levels seen at a particular position maycator that there is transcriptional activity in this
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represent either partial modification of all nucleo- “poised”—as a prelude to subsequent increases in
transcription. It is possible that several of the 14somes at that position, full modification of a fraction
of DNA molecules in the population, or a combina- genes that showed changes in H3K4me3 levels in the
absence of changes in mRNA levels may belong totion of both. More work is required to distinguish
between these various possibilities. this category.
Our results also demonstrate that genes that show
changes in mRNA levels, in general, also show
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